Parallel Advisors’s AstraZeneca AZN Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$974K Sell
13,940
-2,109
-13% -$147K 0.02% 424
2025
Q1
$1.18M Buy
16,049
+1,125
+8% +$82.7K 0.03% 357
2024
Q4
$978K Sell
14,924
-6,072
-29% -$398K 0.02% 404
2024
Q3
$1.64M Buy
20,996
+243
+1% +$18.9K 0.04% 279
2024
Q2
$1.62M Buy
20,753
+1,983
+11% +$155K 0.04% 266
2024
Q1
$1.27M Buy
18,770
+4,458
+31% +$302K 0.03% 310
2023
Q4
$964K Sell
14,312
-169
-1% -$11.4K 0.03% 338
2023
Q3
$981K Buy
14,481
+650
+5% +$44K 0.03% 316
2023
Q2
$990K Buy
13,831
+427
+3% +$30.6K 0.03% 316
2023
Q1
$930K Buy
13,404
+178
+1% +$12.4K 0.03% 326
2022
Q4
$897K Sell
13,226
-824
-6% -$55.9K 0.04% 278
2022
Q3
$770K Buy
14,050
+2,600
+23% +$142K 0.04% 288
2022
Q2
$757K Sell
11,450
-228
-2% -$15.1K 0.03% 289
2022
Q1
$784K Sell
11,678
-2,502
-18% -$168K 0.03% 318
2021
Q4
$826K Buy
14,180
+223
+2% +$13K 0.03% 317
2021
Q3
$838K Buy
13,957
+2,268
+19% +$136K 0.03% 290
2021
Q2
$700K Buy
11,689
+655
+6% +$39.2K 0.03% 318
2021
Q1
$549K Sell
11,034
-624
-5% -$31K 0.03% 329
2020
Q4
$583K Sell
11,658
-309
-3% -$15.5K 0.03% 301
2020
Q3
$656K Buy
11,967
+186
+2% +$10.2K 0.04% 250
2020
Q2
$623K Sell
11,781
-253
-2% -$13.4K 0.04% 256
2020
Q1
$537K Buy
12,034
+849
+8% +$37.9K 0.04% 230
2019
Q4
$558K Sell
11,185
-451
-4% -$22.5K 0.04% 263
2019
Q3
$519K Buy
11,636
+1,125
+11% +$50.2K 0.04% 255
2019
Q2
$434K Sell
10,511
-1,080
-9% -$44.6K 0.04% 261
2019
Q1
$469K Buy
11,591
+499
+4% +$20.2K 0.05% 228
2018
Q4
$421K Buy
11,092
+876
+9% +$33.2K 0.06% 218
2018
Q3
$404K Sell
10,216
-50
-0.5% -$1.98K 0.05% 241
2018
Q2
$360K Buy
10,266
+36
+0.4% +$1.26K 0.05% 229
2018
Q1
$358K Buy
10,230
+966
+10% +$33.8K 0.06% 227
2017
Q4
$321K Sell
9,264
-258
-3% -$8.94K 0.05% 241
2017
Q3
$313K Buy
9,522
+2,537
+36% +$83.4K 0.05% 241
2017
Q2
$211K Buy
6,985
+2,459
+54% +$74.3K 0.04% 307
2017
Q1
$138K Buy
4,526
+964
+27% +$29.4K 0.03% 367
2016
Q4
$97K Buy
+3,562
New +$97K 0.02% 395